Select a company
Company Stage
-
Private (seed)
-
Private (post-seed)
-
Quoted
Sector
-
Energy and Renewables
-
IT & Communications
-
Chemicals & Materials
-
Pharma & Biotech
-
Medical Equipment & Supplies
University
-
King's College London
-
Queen Mary, University of London
-
University of Bath
-
University of Bristol
-
University of Cardiff (Fusion IP)
-
University of Glasgow
-
University of Leeds
-
University of Oxford
-
University of Sheffield (Fusion IP)
-
University of Southampton
-
University of Surrey
-
University of York
-
Other
Retroscreen Virology Group plc
Retroscreen Virology is Europe's leading contract virology research company. The work it carries out is dedicated to creating the next generation of antivirals and vaccines in the field of biomedical research. Its research includes both pre-clinical and clinical projects. It currently conducts and co-ordinates several clinical trials per year involving student/staff volunteers or patients in general practice, particularly involving influenza or common cold viruses or vaccines.
|
As at 30 June 2011 |
IP Group holding |
IP Venture Fund* holding |
33.9% |
14.4% |
| |
*IP Group has a 10%
economic interest in IP
Venture Fund |
Holdings represent undiluted beneficial equity interest excluding debt
Related news
10 May 2012
03 May 2012
There is currently no news available.
More portfolio news